Is a complete LON/0VQA research report available?

Question

Accepted Answer

No complete published report is available for lon/0VQA (LON/0VQA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	2.8B
Net income (ttm)	-403.1M
EPS (ttm)	-$3.52
Volume	2,506
Beta	0.69

Metric	Value
Country	United States
Country code	UK
Employees	65
Employees Change	20%
Employees Change Percent	64.52
Enterprise value	$2.4B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US92686J1060
Last refreshed	2026-09-11
Market cap	$2.8B
Price	$32.24
Price currency	USD
Sector	Healthcare
Sector PE	21.2
Sector PE Fwd	13.53
Sic	2836
Symbol	lon/0VQA
Website	https://www.vikingtherapeutics.com

Metric	Value
Earnings Yield	-14.31%
P/B ratio	9.15x

Metric	Value
Net Income	$-403.1M
Net Income Growth Years	0%
Profit Per Employee	$-6.2M
ROA	-51.86
Roa5y	-21.32
ROCE	-135.8
ROE	-88.85
Roe5y	-32.87
ROIC	-57.91

Metric	Value
Cagr1y	28.11%
Cagr3y	26.09%
Cagr5y	37.91%
EPS Growth Years	0
Revenue Growth Years	0x

LON/0VQA (LON/0VQA)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0VQA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0VQA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0VQA

Frequently asked questions

Metric	Value
Assets	$393.4M
Cash	$378.1M
Current Assets	$382.7M
Current Liabilities	$81.1M
Debt	$3.1M
Debt Equity	$0.01
Equity	$307.7M
Interest Coverage	-69,998
Liabilities	$85.6M
Long Term Assets	$10.6M
Long Term Liabilities	$4.5M
Net Cash	$375M
Net Cash By Market Cap	$13.32
Net Cash Growth	-38.33%
Net Debt Equity	$-1.22
Tangible Book Value	$307.7M
Tangible Book Value Per Share	$2.64
WACC	8.01

Metric	Value
Current ratio	4.72
Net Working Capital	$-70.5M
Quick ratio	4.57
Working Capital	$307.4M

Metric	Value
1Y total return	28.09%
200-day SMA	33.46
3Y total return	100.5%
50-day SMA	35
50-day SMA vs 200-day SMA	50over200
5Y total return	398.69%
All Time High	99.3
All Time High Change	-67.53%
All Time High Date	2024-02-28
All Time Low	2.15
All Time Low Change	1,399.53%
All Time Low Date	2022-05-24
ATR	1.55
Beta	0.69
Ch YTD	-8.52
High	33.1
High52	43.15
High52 Date	2025-11-12
High52ch	-25.29%
Low	31.9
Low52	23.09
Low52 Date	2025-09-18
Low52ch	39.64%
Ma50ch	-7.9%
Price vs 200-day SMA	-3.64%
RSI	41.38
RSI Monthly	48.64
RSI Weekly	48.1
Sharpe ratio	0.63x
Sharpe Ratio3y	0.65x
Sortino ratio	1.12
Sortino Ratio3y	1.35
Total Return	-2.64%
Tr YTD	-8.52
Tr1m	-5.1%
Tr1w	-2.69%
Tr3m	11.13%

Metric	Value
Float	113,731,522%
Shares Insiders	2.46%
Shares Institutions	65.62%
Shares Qo Q	0.6%
Shares Yo Y	2.64%
Short Ratio	9.99

Metric	Value
Adjusted OCF	-337,063,260.5
Average Volume	10,313.45x
Bv Per Share	2.64
Ch1m	-5.1
Ch1w	-2.69
Ch1y	28.09
Ch3m	11.13
Ch3y	100.5
Ch5y	398.7
Ch6m	-3.03
Change	-1.59%
Change From Open	-2.15
Close	32.76
Days Gap	0.58
Depreciation Amortization	332,749.4
Dollar Volume	80,793.4
Earnings Date	2026-10-21
EBIT	$-422.1M
EPS	$-3.52
F Score	1
Financing CF	83,846,110
Fiscal Year End	December
Founded	2,012
Investing CF	300,920,001
Is Primary Listing	0
Last Earnings Date	2026-07-29
Last Report Date	2026-06-30
Ma150	33.18
Ma150ch	-2.82%
Ma20	33.52
Ma20ch	-3.81%
Net CF	69,401,450
Next Earnings Date	2026-10-21
Open	32.95
Position In Range	28.33
Ppne	2,965,166.4
Price Date	2026-09-10
Ptbv Ratio	9.15
Relative Volume	0.21x
Share Based Comp	28,183,104
Tr6m	-3.03%
Volume	2,506